SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.144
AS - Asia 5.205
EU - Europa 2.924
SA - Sud America 839
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 99
OC - Oceania 13
Totale 20.332
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.898
SG - Singapore 1.854
CN - Cina 1.487
BR - Brasile 634
UA - Ucraina 606
VN - Vietnam 541
GB - Regno Unito 434
DE - Germania 426
HK - Hong Kong 411
IT - Italia 381
TR - Turchia 349
FR - Francia 200
PL - Polonia 184
FI - Finlandia 178
SE - Svezia 166
RU - Federazione Russa 128
BD - Bangladesh 124
CA - Canada 112
JP - Giappone 106
IN - India 91
MX - Messico 78
AR - Argentina 73
ZA - Sudafrica 52
IQ - Iraq 48
NL - Olanda 47
BE - Belgio 40
AT - Austria 36
EC - Ecuador 35
CO - Colombia 32
ES - Italia 31
ID - Indonesia 29
PK - Pakistan 24
VE - Venezuela 24
JM - Giamaica 18
UZ - Uzbekistan 16
LT - Lituania 15
CL - Cile 14
IR - Iran 14
PH - Filippine 14
SA - Arabia Saudita 14
MA - Marocco 13
MY - Malesia 12
CR - Costa Rica 11
PY - Paraguay 11
KR - Corea 10
HN - Honduras 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
TN - Tunisia 7
NP - Nepal 6
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
BY - Bielorussia 5
LB - Libano 5
OM - Oman 5
BO - Bolivia 4
CH - Svizzera 4
JO - Giordania 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
MZ - Mozambico 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
CG - Congo 1
Totale 20.221
Salva come PNG Salva come JPEG
Città #
Singapore 1.237
Ashburn 1.138
Woodbridge 891
Fairfield 841
San Jose 786
Jacksonville 620
Houston 609
Chandler 504
Beijing 474
Ann Arbor 458
Santa Clara 457
Hong Kong 405
Seattle 337
Wilmington 331
Council Bluffs 321
Cambridge 283
New York 256
Nanjing 194
Izmir 188
Warsaw 172
Los Angeles 169
Ho Chi Minh City 152
Dallas 144
Hanoi 144
Princeton 134
Tokyo 100
Lauterbourg 97
Buffalo 87
San Diego 87
Munich 78
Milan 69
São Paulo 67
Boardman 63
Shanghai 59
Shenyang 58
Orem 54
Mexico City 52
Tianjin 52
Chicago 50
Helsinki 48
Nanchang 47
Toronto 41
The Dalles 40
Brussels 39
Frankfurt am Main 39
Hefei 39
Hebei 38
Jiaxing 37
San Mateo 34
Ferrara 32
Brooklyn 30
London 30
Montreal 30
Vienna 30
Da Nang 28
Changsha 27
San Francisco 27
Chennai 26
Jinan 24
Philadelphia 24
Johannesburg 23
Ningbo 23
Phoenix 23
Washington 23
Baghdad 21
Denver 21
Guangzhou 21
Rome 21
Norwalk 20
Poplar 20
Stockholm 20
Boston 19
Falls Church 19
Moscow 19
Rio de Janeiro 19
Mountain View 17
Turku 17
Ankara 16
Augusta 16
Hải Dương 16
Manchester 16
Amsterdam 15
Bologna 15
Dearborn 15
Kingston 15
Kunming 15
Leawood 15
Atlanta 14
Auburn Hills 14
Haiphong 14
Medellín 13
Tashkent 13
Belo Horizonte 12
Biên Hòa 12
Charlotte 12
Falkenstein 12
Mumbai 12
Naples 12
Orange 12
Verona 12
Totale 13.592
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 339
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 285
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 275
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 274
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 268
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 264
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 253
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 251
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 250
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 241
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 240
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 236
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 235
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 233
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 229
HSV as a vector in vaccine development and gene therapy 222
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 215
Capitolo 55 Retrovirus 214
Herpesvirus-based vaccines 214
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 212
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 211
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 211
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 207
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 206
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 205
Replication-competent herpes simplex vectors: design and applications 205
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 203
Herpes Simplex Virus Growth, Preparation, and Assay 201
HSV as a vector in vaccine development and gene therapy 199
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 195
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 191
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 190
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 190
Purinergic Signaling: A New Pharmacological Target Against Viruses? 190
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 187
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 185
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 184
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 184
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 183
null 179
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 178
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 177
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 176
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 175
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 174
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 173
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 172
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 171
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 170
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 170
Herpesvirus/retrovirus chimeric vectors 169
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 168
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 168
Capitolo 44 Herpesviridae 167
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 166
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 166
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 166
State of viral DNA in BK virus-transformed rabbit cells 164
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 164
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 164
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 163
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 160
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 159
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 157
HSV Recombinant Vectors for Gene Therapy 157
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 154
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 154
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 153
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 151
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 150
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 149
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 147
HSV-1 virions engineered for specific binding to cell surface receptors 145
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 145
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 143
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 138
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 137
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 137
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 134
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 132
Molecular diagnosis of herpes simplex encephalitis 132
Transformation by defined regions of herpes simplex virus DNA. 132
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 131
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 127
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 127
Niosomes for vaginal administration of an antiherpetic peptide 126
Gene therapy of the nervous system by herpes virus vectors 125
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 125
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale. 124
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 122
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 118
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 118
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 118
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 117
Virus vectors for immunoprophylaxis 114
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 114
Molecular approaches to inhibit HIV-1 tat expression and functions 113
Niosomes containing HSV immunogens as possible vaccine against genital herpes 112
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 111
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 109
Totale 17.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.057
Totale 94.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.212 0 0 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20267.128 755 273 643 959 1.054 496 761 357 666 751 312 101
2026/2027928 245 394 289 0 0 0 0 0 0 0 0 0
Totale 20.332